Free radical scavenging activity of sulfonylureas: A clinical assessment of the effect of gliclazide

Terapevticheskii Arkhiv

Volumn 73, Issue 4, 2001, Pages 27-31

  Jennings, P E ^a   Belch, J J F ^a  

^a NONE

Author keywords

Diabetes; Free radicals; Gliclazide; Sulfonylurea

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; SCAVENGER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; GLICLAZIDE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; TIME FACTORS;

EID: 0035236267     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wolff S. P., Jiang Z. Y., Hunt J. V. Protein glycation and oxidative stress diabetes and ageing. Free Radic. Biol. Med. 1991; 10: 339-352.
2. Brownlee M., Vlassara H., Cerami A. The pathogenetic role of nonenzymatic glycosylation in diabetic complications. In: Crabbe M. J. C. (ed.) Diabetic complications: scientific and clinical aspects. Edinburgh: UK, Churchill Livingstone; 1987. 94-139.
3. Scott N. A., Jennings P. E., Brown J. et al. Gliclazidc a free radical scavenger. Eur. J. Pharmacol. 1991; 208: 175-177.
4. Tsuboi T., Fuijitani B., Maeda T. et al. Effects of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets. Thromb. Res. 1981; 21: 103-110.
5. Ponari O., Givardi E., Megta S. et al. Anti-platelet effects of long term treatment with gliclazide on platelet function in patients with diabetes mellitus. Ibid. 1979; 16: 191-203.
6. Florkowski C. M., Richardson M. R., Le Guen C. et al. Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent mellitus. Diabet. Res. 1988; 9: 87-90.
7. Aust S. Lipid peroxidation. In: Greenwald R. A. (ed.) Handbook of methods for oxygen free radicals research. Boca Raton, FI.: LRL; 1987, 203-207.
8. Misra H. P., Fridovich I. Superoxide radical and free radicals in clinical chemistry. Ann. Clin. Biochem. 1979; 13: 393-398.
9. O'Brien R. C., Luo M. Gliclazide inhibits low density lipoprotein (LDL) oxidation in-vitro. Diabetologia 1995; 38 (suppl. I): A197.
10. Desfaits A. C., Serri O., Renier G. Gliclazide decreases cellmediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial-cells induced by oxidatively modified LDL. Metabolism 1997; 46: 1150-1156.
11. Akanuma Y., Kosaka K., Kanazawa Y. et al. Long term comparison on oral hypoglycaemic agents in diabetic retinopathy. Diabet. Res. Clin. Pract. 1988; 5: 81-90.